Clinical Research Directory
Browse clinical research sites, groups, and studies.
V+PSF-M for Tobacco Cessation in HIV Care in India
Sponsor: University of Colorado, Denver
Summary
The goal of this research study is to test an intervention to help quit tobacco use in participants with Human Immunodeficiency Virus (HIV). The study interventions used in this research study are: * Positively Smoke Free - Mobile (PSF-M) (mobile behavioral program) * Varenicline (or Chantix, apovarenicline, Champix or Nocrav)
Official title: Varenicline and Mobile Behavioral Assistance for Tobacco Cessation in HIV Care in India
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2024-01-02
Completion Date
2026-07-22
Last Updated
2025-06-15
Healthy Volunteers
No
Interventions
Varenicline
Per package dosing, tablet taken orally
Positively Smoke Free Mobile (PSF-M)
Behavioral tobacco cessation intervention for people living with HIV, delivered via mobile phone
Standard Care
Brief cessation advice plus referral to local tobacco quitline
Locations (2)
University of Colorado
Aurora, Colorado, United States
VHS Infectious Disease Medical Centre, CART Clinical Research Site
Chennai, Tamil Nadu, India